Babban nauyin tumor, immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H

An yarda da Pembrolizumab don amfani da ita a cikin kowace cutar kansa tare da babban nauyin maye gurbi

Yuli 2021: Hukumar Abinci da Magunguna ta Amurka (FDA) ta faɗaɗa alamun pembrolizumab (Keytruda), maganin rigakafi, don haɗa kowane ciwon daji tare da babban nauyin maye gurbin (TMB-H). Sabuwar izini shine f..

Cin inabi na iya hana ka daga cutar daji

Wasu bincike sun nuna cin 'ya'yan inabi na iya hana ciwon daji. Ciwon huhu shine nau'in ciwon daji mafi muni a duniya, kuma kashi 80% na mutuwar suna da alaƙa da shan taba. Ko da yake sarrafa taba, tursasawa chemoprevention techniq..